Compare Motilal Oswal with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOTILAL OSWAL vs INDOCO REMEDIES - Comparison Results

MOTILAL OSWAL     Change

Motilal Oswal Financial Services (MOFSL) derives a significant portion of its revenues from equity broking (69% in FY12) for both retail and institutional clients. Accordingly, its revenues and profits are dependent on favourable capital market condi... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MOTILAL OSWAL INDOCO REMEDIES MOTILAL OSWAL/
INDOCO REMEDIES
 
P/E (TTM) x 33.3 50.5 66.0% View Chart
P/BV x 3.5 2.0 175.6% View Chart
Dividend Yield % 1.2 0.7 168.6%  

Financials

 MOTILAL OSWAL   INDOCO REMEDIES
EQUITY SHARE DATA
    MOTILAL OSWAL
Mar-19
INDOCO REMEDIES
Mar-18
MOTILAL OSWAL/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,066317 335.9%   
Low Rs550178 308.7%   
Sales per share (Unadj.) Rs169.0113.1 149.5%  
Earnings per share (Unadj.) Rs20.54.5 458.4%  
Cash flow per share (Unadj.) Rs22.111.8 187.2%  
Dividends per share (Unadj.) Rs8.501.00 850.0%  
Dividend yield (eoy) %1.10.4 260.7%  
Book value per share (Unadj.) Rs209.673.2 286.2%  
Shares outstanding (eoy) m145.6892.15 158.1%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x4.82.2 218.1%   
Avg P/E ratio x39.555.5 71.1%  
P/CF ratio (eoy) x36.521.0 174.2%  
Price / Book Value ratio x3.93.4 114.0%  
Dividend payout %41.522.4 185.4%   
Avg Mkt Cap Rs m117,69522,830 515.5%   
No. of employees `0003.25.5 59.6%   
Total wages/salary Rs m5,0182,209 227.1%   
Avg. sales/employee Rs Th7,579.81,910.1 396.8%   
Avg. wages/employee Rs Th1,544.4405.0 381.4%   
Avg. net profit/employee Rs Th918.175.5 1,216.8%   
INCOME DATA
Net Sales Rs m24,62710,419 236.4%  
Other income Rs m5647 118.3%   
Total revenues Rs m24,68210,466 235.8%   
Gross profit Rs m9,1961,349 681.6%  
Depreciation Rs m240677 35.4%   
Interest Rs m5,169235 2,198.4%   
Profit before tax Rs m3,844484 794.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m800-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m94172 1,299.3%   
Profit after tax Rs m2,983412 724.7%  
Gross profit margin %37.312.9 288.4%  
Effective tax rate %24.515.0 163.6%   
Net profit margin %12.14.0 306.6%  
BALANCE SHEET DATA
Current assets Rs m22,9925,373 427.9%   
Current liabilities Rs m45,6994,157 1,099.4%   
Net working cap to sales %-92.211.7 -790.1%  
Current ratio x0.51.3 38.9%  
Inventory Days Days068 0.0%  
Debtors Days Days22573 308.9%  
Net fixed assets Rs m2,6706,244 42.8%   
Share capital Rs m146184 79.1%   
"Free" reserves Rs m30,3896,566 462.9%   
Net worth Rs m30,5346,750 452.4%   
Long term debt Rs m25,3331,233 2,054.9%   
Total assets Rs m104,81812,363 847.9%  
Interest coverage x1.73.1 57.0%   
Debt to equity ratio x0.80.2 454.3%  
Sales to assets ratio x0.20.8 27.9%   
Return on assets %7.85.2 148.7%  
Return on equity %9.86.1 160.2%  
Return on capital %16.39.0 180.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m01,143 0.0%   
Net fx Rs m02,619 0.0%   
CASH FLOW
From Operations Rs m2,0621,227 168.0%  
From Investments Rs m39-1,360 -2.9%  
From Financial Activity Rs m-1,422-388 366.8%  
Net Cashflow Rs m679-521 -130.4%  

Share Holding

Indian Promoters % 74.1 59.2 125.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 12.5 60.0%  
FIIs % 5.3 6.0 88.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.1 22.4 58.5%  
Shareholders   11,283 12,805 88.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MOTILAL OSWAL With:   CHOLAMANDALAM INVEST.  TATA INVESTMENT  REPCO HOME  COMPACT DISC  FINOLEX INDUSTRIES  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

MOTILAL OSWAL Announces Quarterly Results (4QFY19); Net Profit Up 0.3% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MOTILAL OSWAL has posted a net profit of Rs 1 bn (up 0.3% YoY). Sales on the other hand came in at Rs 7 bn (down 12.7% YoY). Read on for a complete analysis of MOTILAL OSWAL's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MOTILAL OSWAL SHARE PRICE


Nov 15, 2019 (Close)

TRACK MOTILAL OSWAL

  • Track your investment in MOTILAL OSWAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MOTILAL OSWAL - S.P. APPARELS COMPARISON

COMPARE MOTILAL OSWAL WITH

MARKET STATS